MX9102686A - Carboxamidas de dihidrobenzofurano y proceso para su preparacion. - Google Patents

Carboxamidas de dihidrobenzofurano y proceso para su preparacion.

Info

Publication number
MX9102686A
MX9102686A MX9102686A MX9102686A MX9102686A MX 9102686 A MX9102686 A MX 9102686A MX 9102686 A MX9102686 A MX 9102686A MX 9102686 A MX9102686 A MX 9102686A MX 9102686 A MX9102686 A MX 9102686A
Authority
MX
Mexico
Prior art keywords
dihydrobenzofurane
carboxamides
preparation
disorders
azabicyclics
Prior art date
Application number
MX9102686A
Other languages
English (en)
Inventor
Silvia De Benardinis
Marcelo Marchi
Mario Varasi
Angelo Bedeschi
Walter Cabri
Ilaria Candiani
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909028104A external-priority patent/GB9028104D0/en
Priority claimed from GB919107140A external-priority patent/GB9107140D0/en
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of MX9102686A publication Critical patent/MX9102686A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Se describe un compuesto de la fórmula (I): en la que A es un sustituyente seleccionado a partir del grupo que consiste de: en las R'es hidrógeno o metilo, m es cero ó 1, y el símbolo quiere decir que los anillos azabicíclicos pueden estar en la orientación alfa o en la orientación beta-, y las sales farmacéuticamente aceptables del mismo, que es útil en el tratamiento de las alteraciones del SNC, las alteraciones de la motilidad de los intestinos, y/o la emesis y/o el dolor en los mamíferos, y/o la migraña.
MX9102686A 1990-12-27 1991-12-19 Carboxamidas de dihidrobenzofurano y proceso para su preparacion. MX9102686A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909028104A GB9028104D0 (en) 1990-12-27 1990-12-27 Dihydrobenzofuran carboxamides and process for their preparation
GB919107140A GB9107140D0 (en) 1991-04-05 1991-04-05 Dihydrobenzofuran carboxamides and process for their preparation

Publications (1)

Publication Number Publication Date
MX9102686A true MX9102686A (es) 1994-01-31

Family

ID=26298184

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102686A MX9102686A (es) 1990-12-27 1991-12-19 Carboxamidas de dihidrobenzofurano y proceso para su preparacion.

Country Status (19)

Country Link
US (1) US5362740A (es)
EP (1) EP0493031B1 (es)
JP (1) JP3453394B2 (es)
KR (1) KR920012083A (es)
AT (1) ATE127119T1 (es)
AU (1) AU638665B2 (es)
CA (1) CA2058264C (es)
DE (1) DE69112594T2 (es)
DK (1) DK0493031T3 (es)
ES (1) ES2079590T3 (es)
FI (1) FI97806C (es)
GR (1) GR3017872T3 (es)
HU (1) HU208538B (es)
IE (1) IE914488A1 (es)
IL (1) IL100432A (es)
MX (1) MX9102686A (es)
NZ (1) NZ241067A (es)
PT (1) PT99886B (es)
TW (1) TW242624B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9028105D0 (en) * 1990-12-27 1991-02-13 Erba Carlo Spa Process for the preparation of substituted benzofuran derivatives
JP2999669B2 (ja) * 1993-08-24 2000-01-17 株式会社三和化学研究所 ベンゾ［ｂ］フランカルボキサミド誘導体、その製法及び用途
JPH0820586A (ja) * 1994-07-05 1996-01-23 Sanwa Kagaku Kenkyusho Co Ltd １−アザビシクロ［３．３．０］オクタン誘導体、その塩及び製法並びに用途
JPH0873463A (ja) 1994-07-05 1996-03-19 Sanwa Kagaku Kenkyusho Co Ltd ベンゾピランカルボキサミド誘導体、その塩及び製法並びに用途
AR036040A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
AR036041A1 (es) * 2001-06-12 2004-08-04 Upjohn Co Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
JP2005527472A (ja) * 2001-09-12 2005-09-15 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 疾患治療のための置換された７−アザ［２．２．１］ビシクロヘプタン
DK1432707T3 (da) 2001-10-02 2012-06-11 Pharmacia & Upjohn Co Llc Azabicyklisk-substituerede kondenserede heteroarylforbindelser til behandling af sygdomme
US6849620B2 (en) 2001-10-26 2005-02-01 Pfizer Inc N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
US6951868B2 (en) 2001-11-09 2005-10-04 Pfizer Inc. Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease
US6894042B2 (en) * 2002-02-19 2005-05-17 Pharmacia & Upjohn Company Azabicyclic compounds for the treatment of disease
CA2476681A1 (en) * 2002-02-19 2003-08-28 Bruce N. Rogers Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease
JP2006506395A (ja) * 2002-11-01 2006-02-23 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ＣＮＳ疾患の治療のための、α７ニコチンアゴニスト活性及び５ＨＴ３アンタゴニスト活性を有する化合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3705165A (en) * 1970-08-05 1972-12-05 Elmar Sturm N-carbonyl derivatives of azabicyclooctanes
GB1593146A (en) * 1976-11-05 1981-07-15 Beecham Group Ltd Octahydro-quinolizinyl benzamide derivatives
IL59004A0 (en) * 1978-12-30 1980-03-31 Beecham Group Ltd Substituted benzamides their preparation and pharmaceutical compositions containing them
IL61642A0 (en) * 1979-12-20 1981-01-30 Beecham Group Ltd Aniline derivatives,their preparation and pharmalceutical compositions containing them
EP0099194A3 (en) * 1982-07-03 1984-04-11 Beecham Group Plc Novel benzamides
EP0135545A1 (en) * 1983-02-19 1985-04-03 Beecham Group Plc Azabicycloalkyl benzamide and anilide derivatives
US4888353A (en) * 1986-02-28 1989-12-19 Erbamont, Inc. Carboxamides useful as antiemetic or antipsychotic agents
GB8718345D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa N-substituted benzamides
US4997956A (en) * 1989-06-14 1991-03-05 Eli Lilly And Company Certain 2,3-dihydro-2;2-dimethyl-benzothiophene carboxylic acids which are intermediates
US4921982A (en) * 1988-07-21 1990-05-01 Eli Lilly And Company 5-halo-2,3-dihydro-2,2-dimethylbenzofuran-7-carboxylic acids useful as intermediates for 5-HT3 antagonists
US4863921A (en) * 1988-04-27 1989-09-05 Rorer Pharmaceutical Corporation Dibenzofurancarboxamides and their pharmaceutical compositions and methods
JPH0232077A (ja) * 1989-06-16 1990-02-01 Yoshitomi Pharmaceut Ind Ltd ベンゾフランおよびベンゾピラン化合物
GB9028105D0 (en) * 1990-12-27 1991-02-13 Erba Carlo Spa Process for the preparation of substituted benzofuran derivatives

Also Published As

Publication number Publication date
NZ241067A (en) 1993-03-26
CA2058264C (en) 1999-03-16
AU8995891A (en) 1992-07-02
IL100432A (en) 1996-01-19
ES2079590T3 (es) 1996-01-16
DE69112594D1 (de) 1995-10-05
FI916058A (fi) 1992-06-28
JPH04295476A (ja) 1992-10-20
KR920012083A (ko) 1992-07-25
FI97806B (fi) 1996-11-15
PT99886A (pt) 1992-12-31
PT99886B (pt) 1999-06-30
IE914488A1 (en) 1992-07-01
DK0493031T3 (da) 1995-09-25
FI97806C (fi) 1997-02-25
US5362740A (en) 1994-11-08
CA2058264A1 (en) 1992-06-28
FI916058A0 (fi) 1991-12-20
JP3453394B2 (ja) 2003-10-06
DE69112594T2 (de) 1996-02-01
TW242624B (es) 1995-03-11
HU208538B (en) 1993-11-29
HUT59678A (en) 1992-06-29
IL100432A0 (en) 1992-09-06
EP0493031B1 (en) 1995-08-30
HU914093D0 (en) 1992-03-30
GR3017872T3 (en) 1996-01-31
AU638665B2 (en) 1993-07-01
EP0493031A1 (en) 1992-07-01
ATE127119T1 (de) 1995-09-15

Similar Documents

Publication Publication Date Title
MX9102686A (es) Carboxamidas de dihidrobenzofurano y proceso para su preparacion.
ES2092113T3 (es) Derivados fluoroalcoxibencilamino de heterociclos que contienen nitrogeno.
ES2160237T3 (es) O-carbamoil-fenilalaninol que tiene sustituyente en anillo de benceno, sus sales farmaceuticamente utiles, y metodo para la preparacion de los mismos.
HUT56092A (en) Process for producing 2-amino-pyrimidine-4-carboxamide derivatives and pharmaceutical compositions containing them
DK281482A (da) Fremgangsmaade til fremstilling af 2-aryl-3,4-diazabicyclo(4.n.o)alken-(2)-on-5-forbindelser
PT81810A (en) Process for preparing 6,7-disubstituted 1-cyclopropyl-1,4-di-hydro-oxo-1,8-naphtyridine-3-carboxylic acids
NO885386D0 (no) Bisfenylalkylpiperzin-derivater, en fremgangsmaate ved fremstilling og et farmasoeytisk preparat.
SE8005943L (sv) Piperazinderivat som cirkulationsforhojande emne
ES2026555T3 (es) Derivados del piridoinol; su aplicacion a titulo de medicamentos y las composiciones que los contienen.
ES2183492T3 (es) Nuevos derivados de nitrono,su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ECSP941050A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene
FI103887B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten imidatsolyylimetyyli-pyridiinien valmistamiseksi
NO873564L (no) Nye tyroninderivater.
FI910159A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 9a-hydroxi-3-oxo-4,24(25)-stigmastadien-26 -syraderivat.
SE8206548L (sv) Bensylidenderivat
DE3671437D1 (de) Herstellung von chlorothalonyl.
NO952559L (no) N-acyl-pyrrolidiner og medikamenter for behandling eller prevensjon av cholecystokinin- og gastrin-relaterte mangler
ES2036219T3 (es) 2,2; 6,6-dietilen-3-oxo-17alfa-pren-4-en-21,17alfa-carbolactonas, procedimiento para su preparacion y preparados farmaceuticos que las contienen.
SE7903233L (sv) Bensylidenestrar
AR246970A1 (es) Un procedimiento para preparar esteres de hexahidro-8-hidroxi-2,6-metano-2h-quinozilin-(4h)-ona y compuestos relacionados.
ES2089439T3 (es) Nuevos derivados amidicos de 1-amino-octahidro-pirido-(2,1-c)-(1,4)-oxazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
CO4290422A1 (es) Derivados de carbazol substituidos, proceso para su prepara- cion y composiciones farmaceuticas que los contienen
ES2179550T3 (es) 15-metil-ciclopropanoesteroides y proceso para su preparacion.
ATE221068T1 (de) Anellierte beta-carboline

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees